These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 22554675)
1. Cyclosporine immunosuppression does not prevent the production of donor-specific antibody capable of mediating allograft vasculopathy. Gareau AJ; Nashan B; Hirsch GM; Lee TD J Heart Lung Transplant; 2012 Aug; 31(8):874-80. PubMed ID: 22554675 [TBL] [Abstract][Full Text] [Related]
2. Contribution of B cells and antibody to cardiac allograft vasculopathy. Gareau A; Hirsch GM; Lee TD; Nashan B Transplantation; 2009 Aug; 88(4):470-7. PubMed ID: 19696629 [TBL] [Abstract][Full Text] [Related]
3. Aortic allograft vasculopathy is mediated by CD8(+) T cells in Cyclosporin A immunosuppressed mice. Vessie EL; Hirsch GM; Lee TD Transpl Immunol; 2005 Oct; 15(1):35-44. PubMed ID: 16223671 [TBL] [Abstract][Full Text] [Related]
4. CD8(+) T cells mediate aortic allograft vasculopathy under conditions of calcineurin immunosuppression: role of IFN-gamma and CTL mediators. Nejat S; Zaki A; Hirsch GM; Lee TD Transpl Immunol; 2008 May; 19(2):103-11. PubMed ID: 18503885 [TBL] [Abstract][Full Text] [Related]
5. CD8+ T cells mediate aortic allograft vasculopathy by direct killing and an interferon-gamma-dependent indirect pathway. Skaro AI; Liwski RS; Zhou J; Vessie EL; Lee TD; Hirsch GM Cardiovasc Res; 2005 Jan; 65(1):283-91. PubMed ID: 15621057 [TBL] [Abstract][Full Text] [Related]
6. Relative Frequencies of Alloantigen-Specific Helper CD4 T Cells and B Cells Determine Mode of Antibody-Mediated Allograft Rejection. Alsughayyir J; Chhabra M; Qureshi MS; Mallik M; Ali JM; Gamper I; Moseley EL; Peacock S; Kosmoliaptsis V; Goddard MJ; Linterman MA; Motallebzadeh R; Pettigrew GJ Front Immunol; 2018; 9():3039. PubMed ID: 30740108 [TBL] [Abstract][Full Text] [Related]
7. Effect of alloantibodies on corneal allograft survival. Hegde S; Mellon JK; Hargrave SL; Niederkorn JY Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1012-8. PubMed ID: 11923241 [TBL] [Abstract][Full Text] [Related]
9. mTOR Inhibition Suppresses Posttransplant Alloantibody Production Through Direct Inhibition of Alloprimed B Cells and Sparing of CD8+ Antibody-Suppressing T cells. Avila CL; Zimmerer JM; Elzein SM; Pham TA; Abdel-Rasoul M; Bumgardner GL Transplantation; 2016 Sep; 100(9):1898-906. PubMed ID: 27362313 [TBL] [Abstract][Full Text] [Related]
10. Neutrophils are responsible for impaired medial smooth muscle cell recovery and exaggerated allograft vasculopathy in aortic allografts exposed to prolonged cold ischemia. So M; Lee TD; Hancock Friesen CL J Heart Lung Transplant; 2013 Mar; 32(3):360-7. PubMed ID: 23415317 [TBL] [Abstract][Full Text] [Related]
11. IFN-gamma and Fas/FasL pathways cooperate to induce medial cell loss and neointimal lesion formation in allograft vasculopathy. Hart-Matyas M; Nejat S; Jordan JL; Hirsch GM; Lee TD Transpl Immunol; 2010 Feb; 22(3-4):157-64. PubMed ID: 19895889 [TBL] [Abstract][Full Text] [Related]
12. Contribution of pre-existing vascular disease to allograft vasculopathy in a murine model. Zaki AM; Hirsch GM; Lee TD Transpl Immunol; 2009 Dec; 22(1-2):93-8. PubMed ID: 19632325 [TBL] [Abstract][Full Text] [Related]
13. Effect of cyclosporine on anterior chamber-associated immune deviation with retinal transplantation. Ishioka M; Okamoto S; Streilein JW; Jiang LQ Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2152-60. PubMed ID: 9331279 [TBL] [Abstract][Full Text] [Related]
14. C4d deposition in cardiac allografts correlates with alloantibody. Smith RN; Brousaides N; Grazette L; Saidman S; Semigran M; Disalvo T; Madsen J; Dec GW; Perez-Atayde AR; Collins AB J Heart Lung Transplant; 2005 Sep; 24(9):1202-10. PubMed ID: 16143234 [TBL] [Abstract][Full Text] [Related]
15. Stable kidney function in the second decade after kidney transplantation while on cyclosporine-based immunosuppression. Kandaswamy R; Humar A; Casingal V; Gillingham KJ; Ibrahim H; Matas AJ Transplantation; 2007 Mar; 83(6):722-6. PubMed ID: 17414704 [TBL] [Abstract][Full Text] [Related]
16. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol. Siemionow MZ; Izycki DM; Zielinski M Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512 [TBL] [Abstract][Full Text] [Related]
17. Marked inhibition of transplant vascular sclerosis by in vivo-mobilized donor dendritic cells and anti-CD154 mAb. Wang Z; Morelli AE; Hackstein H; Kaneko K; Thomson AW Transplantation; 2003 Aug; 76(3):562-71. PubMed ID: 12923445 [TBL] [Abstract][Full Text] [Related]
18. Donor CD4 T cells contribute to cardiac allograft vasculopathy by providing help for autoantibody production. Win TS; Rehakova S; Negus MC; Saeb-Parsy K; Goddard M; Conlon TM; Bolton EM; Bradley JA; Pettigrew GJ Circ Heart Fail; 2009 Jul; 2(4):361-9. PubMed ID: 19808360 [TBL] [Abstract][Full Text] [Related]
19. The influence of antigen-dependent and antigen-independent factors on the development of graft vasculopathy in a fully allogeneic cardiac allograft model in the rat. Fiedel S; Bayer J; Schaub M; Heidt MC; Grebe M; Tillmanns H; Stadlbauer TH Transplant Proc; 2009; 41(6):2625-7. PubMed ID: 19715988 [TBL] [Abstract][Full Text] [Related]
20. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells. Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]